Welcome to "The Power of Persistence: From Biotech Incubator to First Product Launch," a three-episode podcast series featuring seasoned experts who share valuable insights and tips about bringing biotech products to market. In this series, we delve into the journey of BioLineRx, a biopharmaceutical company founded in Israel, from its inception as a biotech incubator to achieving FDA approval for its first product, motixafortide.
Check out the podcast episodes below.
⬆- Ep. 3 Looking Ahead: Pipeline Development
- Ep. 2 Optimizing the Right Team for the Right Moment
- Ep. 1 From Incubation to Laser-Focused Biotech Innovation
Ep. 3
Looking Ahead: Pipeline Development
Episode three of "The Power of Persistence" focuses on pipeline development in the biotech industry. Phil Serlin, CEO of BioLineRx, discusses how companies balance launching one product while maintaining pipeline development. Phil emphasizes the versatility of their platform molecule and the various applications it offers, such as stem cell mobilization for different transplantation types and gene therapy. Phil shares insights into how BioLineRx identifies potential partners and leverages existing expertise to expand their pipeline strategically. The discussion underscores the dynamic nature of the biotech industry and the need for companies to seize the moment while preparing for the future.